ConductScience.org, home

Paper32036613

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.

Commons RJ and 2 others. Med J Aust, 2020. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. Papers, record 32036613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32036613

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
PubMed
Journal
Med J Aust
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2023-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Commons RJRobert Jhttps://orcid.org/0000-0002-3359-5632
2McCarthy JSJames S
3Price RNRic N

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoquinolinesMajor topic
AntimalarialsMajor topic
Glucosephosphate Dehydrogenase DeficiencyMajor topic
MalariaMajor topic
Female
Humans
Male
Practice Guidelines as Topic
Primaquine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
200909/Z/16/ZWellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05203744Escalating Monthly Doses of Tafenoquine in Healthy VolunteersBackground

Source ClinicalTrials.gov

Download CSV of trials

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130941413Tafenoquine and G6PD: a primer for clinicians.J Travel Med2019https://conductscience.org/library/papers/30941413PubMed
230350771Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.Am J Trop Med Hyg2019https://conductscience.org/library/papers/30350771PubMed
39598455First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.Am J Trop Med Hyg1998https://conductscience.org/library/papers/9598455PubMed
429499733Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.Malar J2018https://conductscience.org/library/papers/29499733PubMed
529738562Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.PLoS One2018https://conductscience.org/library/papers/29738562PubMed
622293322Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations.Blood Cells Mol Dis2012https://conductscience.org/library/papers/22293322PubMed
722968164Primaquine toxicity forestalls effective therapeutic management of the endemic malarias.Int J Parasitol2012https://conductscience.org/library/papers/22968164PubMed
828893237Methods for the field evaluation of quantitative G6PD diagnostics: a review.Malar J2017https://conductscience.org/library/papers/28893237PubMed
930650326Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.N Engl J Med2019https://conductscience.org/library/papers/30650326PubMed
1030650322Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.N Engl J Med2019https://conductscience.org/library/papers/30650322PubMed
1124360369Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.Lancet2014https://conductscience.org/library/papers/24360369PubMed
1230380095Tafenoquine for travelers' malaria: evidence, rationale and recommendations.J Travel Med2018https://conductscience.org/library/papers/30380095PubMed
1311700577A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.Clin Infect Dis2001https://conductscience.org/library/papers/11700577PubMed

Download CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42373213Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study.BMJ Glob Health2026https://conductscience.org/library/papers/42373213PubMed
41593688Tafenoquine succinate inhibits the growth of the equine piroplasmosis hemoparasites Theileria equi and Babesia caballi.Parasit Vectors2026https://conductscience.org/library/papers/41593688PubMed
41484619Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders.Malar J2026https://conductscience.org/library/papers/41484619PubMed
41029685Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia.Malar J2025https://conductscience.org/library/papers/41029685PubMed
40525408Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40525408PubMed
40437509Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia.Malar J2025https://conductscience.org/library/papers/40437509PubMed
40387615Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in Thailand.Pharmacol Res Perspect2025https://conductscience.org/library/papers/40387615PubMed
40038735In vitro and in silico evaluation of synthetic compounds derived from bi-triazoles against asexual and sexual forms of Plasmodium falciparum.Malar J2025https://conductscience.org/library/papers/40038735PubMed
38699793Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.Ann Lab Med2024https://conductscience.org/library/papers/38699793PubMed
38241389Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing.PLoS One2024https://conductscience.org/library/papers/38241389PubMed
37971260Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against Plasmodium vivax in Australian Defence Force personnel.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/37971260PubMed
37817240Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.Malar J2023https://conductscience.org/library/papers/37817240PubMed
37388931Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review.Front Genet2023https://conductscience.org/library/papers/37388931PubMed
36378465Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.Infect Dis Ther2023https://conductscience.org/library/papers/36378465PubMed
36339627Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure.Front Pharmacol2022https://conductscience.org/library/papers/36339627PubMed
34950624Understanding Malaria Persistence: A Mixed-Methods Study on the Effectiveness of Malaria Elimination Strategies in South-Central Vietnam.Front Public Health2021https://conductscience.org/library/papers/34950624PubMed
34934109Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency.Sci Rep2021https://conductscience.org/library/papers/34934109PubMed
34620901Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.Sci Rep2021https://conductscience.org/library/papers/34620901PubMed
34543346Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.PLoS One2021https://conductscience.org/library/papers/34543346PubMed
34526770Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives.Ther Clin Risk Manag2021https://conductscience.org/library/papers/34526770PubMed

See all 29 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32036613

GET https://conductscience.org/api/papers/v1/32036613/cited_by?page=2